HIKMA FDA Approval ANDA 208695

ANDA 208695

HIKMA

FDA Drug Application

Application #208695

Application Sponsors

ANDA 208695HIKMA

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL62.5MG0BOSENTANBOSENTAN
002TABLET;ORAL125MG0BOSENTANBOSENTAN

FDA Submissions

UNKNOWN; ORIG1AP2019-04-26STANDARD
LABELING; LabelingSUPPL2AP2019-11-06STANDARD
REMS; REMSSUPPL3AP2022-04-29

Submissions Property Types

ORIG1Null7
SUPPL2Null7
SUPPL3Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208695
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"BOSENTAN","activeIngredients":"BOSENTAN","strength":"62.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BOSENTAN","activeIngredients":"BOSENTAN","strength":"125MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/26\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"11\/06\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-11-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.